Table 3 Summary of outcome measurers by treatment group over 6 month follow up
From: The use of a synthetic shoulder patch for large and massive rotator cuff tears – a feasibility study
Outcome measure | Patch group | Non-patch | *Difference in medians patch group vs non-patch, (95% CI) | P-value | ||
|---|---|---|---|---|---|---|
Baseline | 6 months | Baseline | 6 months | |||
Oxford score (/48) | 28 (21–34) | 42 (35–47) | 25 (20–30) | 34 (26–44) | 9.7 (2.3,17.3) | 0.01 |
SPADI | 46.9 (30.8–71.5) | 16.9 (6.9–28.5) | 54.6 (42.3–66.9) | 39.6 (8.9–53.5) | 23.0 (3.0,42.9) | 0.03 |
EQ-5D Index | 0.70 (0.53–0.82) | 0.89 (0.82–0.94) | 0.72 (0.55–0.80) | 0.78 (0.51–0.94) | 0.11 (− 0.04,0.27) | 0.15 |
EQ-5D VAS | 75 (54–80) | 80 (70–90) | 75 (65–90) | 70 (60–80) | 10 (−0.7,20.7) | 0.07 |
Constant score (CS) Total (/100) | 44 (27–54.5) | 57.8 (45.8–66.5) | 42.0 (33.5–51.9) | 55.5 (43.5–64) | 3.0 (−8.1,14.2) | 0.59 |
Pain CS score (/15) | 8 (6.5–8.5) | 2.5 (1.0–4.5) | 8.5 (7–9) | 2.5 (1.0–4.5) | 0.00 (−2.0,2.0) | 0.99 |
ADL CS score (/20) | 8 (5–10) | 16 (13–19) | 8 (6–10) | 10 (8–18) | 6.0 (1.7,10.3) | 0.01 |
ROM CS score (/40) | 24 (14–32) | 33 (27–39) | 25 (18–30) | 35 (24–40) | 4.0 (−11.4,3.4) | 0.28 |
Power CS score (/25) | 4 (2–4) | 6.0 (2–10) | 4 (2–7) | 6.0 (4–10) | 1.3 (−5.0,2.4) | 0.50 |